Impact of Advanced Platelet Rich Fibrin and Enamel Matrix Derivative on Clinical and Molecular Wound Healing Parameters After Surgical Removal of Mandibular Third Molars

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 23, 2022

Primary Completion Date

January 20, 2024

Study Completion Date

March 20, 2024

Conditions
Surgical Wound, HealedPost Operative Pain
Interventions
BIOLOGICAL

Advanced platelet rich fibrin (APRF) clots

15 minutes before surgery, phlebotomy will be performed and two vacutainers containing 10ml of blood will be placed in the centrifuge for 8 min and 200g. Acquired APRF clots will be placed in the extraction alveolus

DEVICE

Enamel matrix derivative (EMD) group

After third molar removal, Pref Gel (EDTA) will be placed on the root surface for 2 min and then removed. Emdogain (EMD) will be placed on the collagen sponge (Botiss, Collacone) and then applied in the wound so that the side of the sponge which is covered with Emdogain is in contact with the root surface.

Trial Locations (1)

11000

School of dental medicine, University of Belgrade, Belgrade

All Listed Sponsors
lead

University of Belgrade

OTHER

NCT06190015 - Impact of Advanced Platelet Rich Fibrin and Enamel Matrix Derivative on Clinical and Molecular Wound Healing Parameters After Surgical Removal of Mandibular Third Molars | Biotech Hunter | Biotech Hunter